AGL Share PerformanceMore
|52 week high||80.00 15/06/17|
|52 week low||32.27 07/09/17|
|52 week change||1.65 (3.35%)|
|4 week volume||1,984,625 23/12/17|
Media for (AGL)
Latest News« previous» nextMore
16/01/2018 - 07:52 StockMarketWire
ANGLE has announced that Professor Stuart Martin from the University of Maryland School of Medicine, USA, will be p...
16/01/2018 - 07:00 RNS
RNS Number: 9414B Angle PLC 16 January 2018 For immediate release 16 January 2018 ANGLE plc ("the Company") WEBINAR: USING THE PARSORTIX TM SYSTEM TO IDENTIFY DRUGS THAT MAY ARREST CANCER METASTASIS ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that Professor Stuart Marti...
10/01/2018 - 10:16 RNS
RNS Number: 4781B Angle PLC 10 January 2018 For Immediate Release 10 January 2018 ANGLE plc ("ANGLE" or "the Company") Notification of Interim Results and Webcast ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 31 October 2017 on Wednesday 31 January 201...
08/01/2018 - 09:48 StockMarketWire
ANGLE said it was delighted to announce that the University Medical Centre Hamburg-Eppendorf together with the Med...
08/01/2018 - 07:00 RNS
RNS Number: 1632B Angle PLC 08 January 2018 For immediate release 8 January 2018 ANGLE plc ("the Company") RESEARCH DEMONSTRATES USE OF PARSORTIX TM LIQUID BIOPSY TO DETECT ARV7 IN PROSTATE CANCER AS A TREATMENT SELECTION BIOMARKER Parsortix-based ARV7 test may provide a wider understanding of ARV7...
27/12/2017 - 11:49 RNS
RNS Number: 3649A Angle PLC 27 December 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: ANGLE plc 1b. Please in...
12/12/2017 - 07:00 RNS
RNS Number: 0247Z Angle PLC 12 December 2017 For immediate release 12 December 2017 ANGLE plc ("the Company") Transfer of Lock-in Shares ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that further to the announcement of 16 November 2017, finnCap and WG Partners have given their written consent to allo...
08/12/2017 - 07:00 RNS
RNS Number: 7584Y Angle PLC 08 December 2017 For immediate release 8 December 2017 ANGLE plc ("the Company") GROUND-BREAKING WORK DEMONSTRATES POTENTIAL FOR PARSORTIX TM LIQUID BIOPSY TO REPLACE SOLID BIOPSY IN METASTATIC BREAST CANCER Direct comparison of a simple blood test processed with the Parso...
|Dividend yield||0 %|
Latest discussion posts More
“Good PR from independent source but no move up”▼
“......is that there is a rise in SP following good news, and then literally the following day, there is a sell off - not vast numbers but significant in the context of this ...”▼
“Agree Claude - we?ll put.”▼
Codes & Symbols
|Symbols||AGL, LSE:AGL, AGL.L, AGL:LN, LON:AGL, XLON:AGL|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment